GALMED PHARMACEUTICALS LTD. (GLMD) Shareholders’ equity 2014–2020
GALMED PHARMACEUTICALS LTD. (GLMD) shareholders’ equity at each fiscal year-end, per SEC filings.
$44.2MFY2020 · since FY2014: $31.4M → $44.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | $44.2M | -36.8% |
| FY2019 | $69.9M | -20.5% |
| FY2018 | $87.9M | +456.5% |
| FY2017 | $15.8M | +42.6% |
| FY2016 | $11.1M | -48.6% |
| FY2015 | $21.5M | -31.4% |
| FY2014 | $31.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice